Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29306718 | 0.99 | DUSP3 (0.32) | DUSP3 | |
| SCHEMBL20072887 | 0.99 | DUSP3 (0.33) | DUSP3 | |
| SCHEMBL18015657 | 0.99 | DUSP3 (0.33) | DUSP3 | |
| SCHEMBL24078155 | 0.98 | DUSP3 (0.32) | DUSP3 | |
| SCHEMBL29306721 | 0.98 | DUSP3 (0.32) | DUSP3 | |
| SCHEMBL25121904 | 0.98 | DUSP3 (0.33) | DUSP3 | |
| SCHEMBL15840207 | 0.96 | DUSP3 (0.31) | DUSP3 | |
| SCHEMBL21397929 | 0.95 | DUSP3 (0.31) | DUSP3 | |
| SCHEMBL15840205 | 0.94 | PDK2 (0.32) | DUSP3 | |
| SCHEMBL19104543 | 0.93 | DUSP3 (0.32) | DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228523-A1 | Metal complexes | UDC IRELAND LTD (IE) | 2024-07-11 | — | — | US | disclosed |
| US-20240228523-A1 | Metal complexes | UDC IRELAND LTD (IE) | 2024-07-11 | — | — | US | disclosed |
| US-11917903-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-11917906-B2 | Compounds that can be used in an organic electronic device | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11917906-B2 | Compounds that can be used in an organic electronic device | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11917903-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-20230354701-A1 | COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP | MERCK PATENT GMBH (DE) | 2023-11-02 | — | — | US | disclosed |
| US-20230354701-A1 | COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP | MERCK PATENT GMBH (DE) | 2023-11-02 | — | — | US | disclosed |
| EP-4271163-A2 | COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP | Merck Patent GmbH (DE) | 2023-11-01 | — | — | EP | disclosed |
| US-20230322826-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-10-12 | — | — | US | disclosed |
| US-20170250353-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170250353-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170141328-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-18 | — | — | US | disclosed |
| US-20170141328-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-18 | — | — | US | disclosed |
| WO-2017032439-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2017-03-02 | — | — | WO | disclosed |
| WO-2016124304-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2016-08-11 | — | — | WO | disclosed |
| WO-2015192941-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-12-23 | — | — | WO | disclosed |
| US-20150337197-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| US-20150337197-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| WO-2014094963-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141328-A1 | COMPOSITIONS FOR ELECTRONIC DEVICES | EFNA1, EPHA6, EPHB6 | DUSP3 3227/4885 |
| US-20240228523-A1 | Metal complexes | MCU, IMMT, SOD1 | DUSP3 2631/4885 |
| US-20230322826-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | DUSP3 3736/4885 |
| US-20170250353-A1 | METAL COMPLEXES | SOD1, AP1M1, AP3M1 | DUSP3 3726/4885 |
| US-20230354701-A1 | COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP | NQO1, ICMT, NUDT1 | DUSP3 4229/4885 |
| US-11917903-B2 | Metal complexes | NCLN, BICRA, AP3M1 | DUSP3 3415/4885 |
| US-20150337197-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, EML4, L1CAM | DUSP3 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.